IPOs
By The Online Investor Staff, updated Sun., Apr. 11, 9:48 PM
| This Slide: #1 of 15 |
Slide #1. VectivBio Holding AG — Initial Public Offering
Company:
VectivBio Holding AG
Proposed Symbol:
VECT
Shares Offered:
7,500,000
Price Per Share:
$17.00
Over-Allotment:
1,125,000
Description:
VectivBio Holding AG, ("Vectiv" or "VectivBio") (Nasdaq: VECT), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need, today announced the pricing of its initial public offering of 7,500,000 ordinary shares at a public offering price of $17.00 per share. The gross proceeds to Vectiv, before deducting underwriting discounts and commissions and offering expenses, are expected to be $127.5 million. All of the ordinary shares are being offered by Vectiv. In addition, Vectiv has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ordinary shares at the initial public offering price, less the underwriting discounts and commissions.
